Post-translational modifications to OLIG2 mediate migration and proliferation of both OPCs and GSCs in development and glioma, respectively (Sun et al., 2011; Hornig et al., 2013; Nevo et al., 2014; Singh et al., 2016). The gene discussed is OLIG2; the disease is glioma.